• Gap26 Connexin 43 Mimetic Peptide: Advanced Use-Cases & Prot

  2026-07-15

  Gap26 enables unprecedented control of gap junction communication in 3D cell models, particularly for dissecting calcium signaling and ATP release. Its validated efficacy and protocol flexibility empower research spanning vascular, neuroprotection, and mechanotransduction studies.

• Methyl-β-cyclodextrin: Technical Use in Membrane Studies

  2026-07-15

  Methyl-β-cyclodextrin is designed for controlled extraction of cholesterol and other lipids from cellular membranes, supporting research on membrane fluidity, lipid raft organization, and cholesterol-dependent signaling. It is not suitable for diagnostic or medical use and should only be applied in rigorous, protocol-driven research workflows.

• AI-Driven Discovery of Senolytics: Insights and Methodologic

  2026-07-14

  The referenced study leverages machine learning to identify potent new senolytic compounds, dramatically lowering drug screening costs. Its approach and findings advance the field of aging and disease research by demonstrating how artificial intelligence can accelerate the discovery of targeted cellular senescence modulators.

• Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Axis Modul

  2026-07-14

  The referenced study uncovers a novel mechanism by which Gramine, a natural indole alkaloid, selectively induces ferroptosis and suppresses triple-negative breast cancer (TNBC) by modulating the CUL3–MTDH ubiquitination axis. These findings provide a mechanistic basis for using Gramine as a research tool to dissect ferroptosis pathways in cancer biology.

• Stat3 and NF-κB Synergy in Fyn Kinase Neurodegeneration Mode

  2026-07-13

  This study reveals that constitutive Fyn kinase activation triggers dopaminergic neuron loss and microglial inflammation in zebrafish, mediated by Stat3 and NF-κB pathway synergy. These findings advance understanding of Parkinson’s disease mechanisms and highlight new opportunities for targeted neuroinflammation research.

• Ambroxol Modulation of Nav1.8, TRPV1, and TRPA1 in Neuropath

  2026-07-13

  This study systematically characterizes how ambroxol modulates human and rat Nav1.8 sodium channels and the human irritant receptors TRPV1 and TRPA1, providing mechanistic insight into its topical analgesic effects for neuropathic pain. The findings reveal species-specific channel inhibition and receptor modulation, advancing translational research on targeted analgesia.

• Applied Use of Y-27632 Dihydrochloride in Stem Cell & Cancer

  2026-07-12

  Y-27632 dihydrochloride empowers researchers to enhance stem cell viability and modulate tumor invasiveness with high precision. Discover hands-on protocols, troubleshooting strategies, and innovative experimental designs that leverage this selective ROCK inhibitor’s unique capabilities.

• Stat3 and NF-κB Mediate Fyn Kinase-Driven Neurodegeneration

  2026-07-10

  This study establishes that constitutive activation of Fyn kinase in zebrafish neurons induces dopaminergic neuron loss and microglial inflammation via Stat3 and NF-κB signaling. The findings clarify mechanistic links relevant to Parkinson’s disease and highlight opportunities for targeted pathway intervention in neurodegeneration models.

• Axitinib (AG 013736): Translational Strategy for VEGF Pathwa

  2026-07-09

  Explore the mechanistic and translational power of Axitinib (AG 013736) in angiogenesis inhibition, tumor growth modulation, and advanced cancer biology research. This thought-leadership article delivers actionable insights for experimental design, protocol optimization, and translational impact, blending rigorous experimental evidence with strategic guidance for next-generation research teams.

• Exo1: Mechanistic Insights into Golgi–ER Membrane Traffickin

  2026-07-09

  Exo1 (methyl 2-(4-fluorobenzamido)benzoate) is a selective inhibitor of the exocytic pathway, enabling precise modulation of Golgi–ER membrane trafficking in preclinical research. Its distinct ARF1-release mechanism offers unique advantages over classic exocytosis inhibitors. Exo1 supports advanced exocytic pathway studies with clearly defined usage parameters and mechanistic boundaries.

• M344 HDAC Inhibitor Suppresses Neuroblastoma Growth In Vivo

  2026-07-08

  The reference study demonstrates that M344, a potent histone deacetylase inhibitor, effectively induces cell cycle arrest and apoptosis in neuroblastoma models, outperforming established HDAC inhibitors in cytostatic and cytotoxic assays. These findings highlight M344’s translational potential in pediatric oncology, with implications for safer and more durable neuroblastoma therapies.

• 6-FAM SE Applications: High-Stability Fluorescent Labeling i

  2026-07-08

  6-FAM SE (6-Carboxyfluorescein N-hydroxysuccinimide ester) outperforms traditional fluorescent dyes in gene sequencing and protein labeling by offering superior hydrolytic stability and signal clarity. This guide details practical workflows, advanced applications, and troubleshooting insights to maximize the power of 6-FAM SE in sensitive molecular and nanoparticle assays.

• Verbascoside: Applied PKC/NF-κB Inhibitor for Osteoclastogen

  2026-07-07

  Verbascoside, a potent PKC/NF-κB inhibitor, empowers researchers to dissect intricate bone metabolism and neuroinflammatory pathways with high reproducibility. Its solubility profile and proven IC50 in key cell models make it invaluable for both signaling studies and advanced osteoclastogenesis workflows.

• Novobiocin Sodium: Applied Workflows for DNA Damage & Antipa

  2026-07-07

  Novobiocin Sodium stands out as an aminocoumarin antibiotic tailored for advanced DNA damage and antiparasitic workflows. This article delivers actionable protocols, troubleshooting strategies, and data-driven insights, empowering researchers to leverage Novobiocin Sodium in both classic and emerging applications.

• Dual Enzyme-Responsive Zwitterionic Peptides for Cancer Sele

  2026-07-06

  This study introduces a zwitterionic peptide amphiphile engineered to respond to two cancer-relevant enzymes, enabling highly selective intralysosomal self-assembly and cancer cell death. The dual-enzyme mechanism achieves a notably high selectivity index and demonstrates tumor regression with minimal off-target toxicity, pointing to a promising strategy for targeted peptide therapeutics.

16288 records 1/1086 page Next 12345 下5页 Last page